Update on Pulmonary Embolism Management Kenneth Rosenfield, MD, MHCDS Mass General Hospital Boston, MA Kenneth Rosenfield, MD, MHCDS Conflicts of Interest • • Consultant – Abbott Vascular – Access Vascular – Capture Vascular – Cardinal Health – Contego – CRUZAR Systems – Endospan – Eximo – InspireMD – MD Insider – Micell – Shockwave – Silk Road – Surmodics – Valcare Equity • – Access Vascular – CardioMEMs – Contego – Embolitech – Icon – Janacare – MD Insider – Micell – PQ Bypass • – Primacea – Shockwave – Vortex Research or Fellowship Support – Abbott Vascular – Atrium – Inari Medical – NIH – Lutonix-Bard Board Member – VIVA Physicians (Not For Profit 501(c) Organization) • www.vivapvd.com PE (and DVT): An international crisis! • High incidence; ubiquitous • Severely under-recognized and undertreated • Significant immediate morbidity/mortality and long-term sequelae • High recurrence rate • Treatments available that reduce morbidity, mortality, and sequelae Kearon C et al Chest 2008; 133: 454S-545S “Treatment gap” in PE •